Archives: MFN News Items

A Stress Test in the Netherlands
In July, our network provider experienced two major service outages, which temporarily impacted our operations – particularly in the Netherlands. It was a testing situation for both us and our partners. However, thanks to fast and clear communication, effective crisis management, and close collaboration, we were able to minimize the impact for our users.

As our partner in the Netherlands put it: it was a tough day, but also a clear proof that we have the right product, the right people, and the right mindset to get through even major challenges. It further strengthens our confidence in the future.

We are now working intensively to build increased redundancy to reduce the risk of future network disruptions. It’s also worth highlighting that users connected via WiFi were not affected at all – demonstrating the value of having multiple connectivity options.

Stable Usage and ARR Growth
As expected, we didn’t see a significant increase in the number of units during July. The vacation period affects many operations, especially in Sweden. But we are pleased to report that:

• The Netherlands saw a 5.5% increase in the number of units – even during the holiday period.
• ARR increased during July, thanks to sales of additional services and upgrades.

This confirms that Dosell is not just being installed – it is continuously used and creating value.

Progress in Sweden
Despite the summer slowdown in many municipalities, our momentum remains strong:

• We won a direct procurement where a municipality, after a successful pilot, is switching from their previous supplier to Dosell and placing an order for 30 units.
• 3 new municipalities will launch in August – continuing our geographic expansion.
• Interest remains high – 15 digital demonstrations are already booked for August with Swedish municipalities.

Comments like “I hear nothing but that it works great” are strong indicators of the stability and value Dosell provides.

Spain – Next Step Toward Wider Rollout
In Spain, our partnership with Ti Medi continues to gain attention. In July, La Vanguardia published an article highlighting how Ti Medi is now taking the next step by working directly with pharmacy chains to scale the use of Dosell.

That said, it’s important to recognize that the concept of medication dispensers is still new to the Spanish market, and it will take some time for both users and healthcare providers to fully appreciate its benefits. In countries like the Netherlands and across the Nordics, the solution has gained broader adoption and is already seen as a natural part of future medication management.

We’re confident that Spain will get there too – and once it does, we expect a classic “ketchup effect.” Ti Medi has a strong presence, a clear plan, and is working methodically to build understanding and demand. This makes them the ideal partner to drive development forward in this important market.

Read the article: La Vanguardia – Ti Medi

Finland – New Market with a Strong Partner
In July, we signed an agreement with AddSecure Smart Care Oy, who will now launch Dosell in the Finnish market. They have already placed their first order and have an ambitious plan for the autumn. This is an important piece in our Nordic expansion, and we look forward to a strong collaboration.

Strong Engagement from Our Shareholders
We are very pleased that so many shareholders have taken advantage of our exclusive offer – where shareholders can receive a Dosell device with a free subscription for a limited time. The offer has already generated many registrations, which shows strong interest and engagement. We hope even more shareholders will take the opportunity to try Dosell and experience the value it creates – both for individuals and society.

Read more and register here: https://dosell.se/aktieagarforman/

Charging Up for a Strong Autumn
Our team has had a well-deserved break during the summer – something that was much needed after an intense start to the year. Although many had to step in briefly during their holidays due to our small and committed team, the recovery time has been important.

Now, we are fully recharged and ready for an eventful autumn.

We have a clear plan, strong partners, and a goal that feels more within reach than ever: to reach SEK 10 million in ARR before the end of the year.

Thank you for following our journey – and thank you to all shareholders, customers, and partners who make it possible.

Through this partnership, iZafe Group gains access to a well-established partner with extensive reach in the Finnish welfare technology sector. AddSecure Smart Care Oy brings many years of experience delivering digital safety solutions to municipalities and home healthcare providers – making them an ideal partner for introducing Dosell in Finland.

Finland represents a market with growing demand for safe, efficient, and user-friendly medication management in the home. By combining proven technology with strong local presence, the partnership creates a solid foundation for long-term commercial success.

“This agreement gives us a strong foothold in Finland and opens up significant growth opportunities. We look forward to working with AddSecure to improve medication adherence and safety for even more people,” says Anders Segerström, CEO of iZafe Group.

June was marked by strategic initiatives and a clear forward focus. The summer months are traditionally quieter, which is also reflected in our budget, but we remain firmly on track toward our stated goal of reaching 10 MSEK in ARR by year-end. Despite seasonal effects, the number of dispensings increased by 5% in June compared to May – a clear indication that Dosell usage continues to rise as more units are deployed and used consistently.

We carried out a directed share issue that brought approximately 10 MSEK into the company, strengthening our position to continue growing in Sweden and across our prioritized international markets.

We also launched an exclusive offer for our shareholders – for a limited time, shareholders can receive a Dosell with a free subscription. This is an opportunity to try the product firsthand, contribute to better medication management, and become an ambassador for tomorrow’s solution.
We’ve already received enthusiastic responses and interest in the offer, which is very encouraging. I truly hope even more shareholders take this chance to try Dosell and experience the value it delivers – both for individuals and for society.

Read more and register here: https://dosell.se/aktieagarforman/

Sweden: Summer Pause in Municipalities – But Strong Momentum in Dialogue and Planning
Swedish municipalities are entering a summer period where many processes slow down due to holidays and temporary staffing. This is reflected in a temporarily slower pace, but we’ve taken the opportunity to focus on preparations for the autumn.

In June, we conducted no fewer than 18 digital product demos for municipalities that have shown curiosity and interest. We’ve also been working intensively on fall planning for the launches and pilots scheduled to begin in September.

Feedback from existing customers remains strong – as one put it: “I hear nothing but that it works great!”

Spain: Ti Medi Expands – Strong Media Coverage and Expansion Planning
Our partner Ti Medi continues to expand through the national pharmacy network and has also gained significant media attention. A recently published article in La Vanguardia about their initiative has spread widely and generated additional interest.

The focus now is to continue scaling within Spain – but also to bring Dosell to new countries. Ti Medi is now preparing for launches in both Portugal and France this fall.

The Netherlands: 21% Growth in June – Over 30 Care Organizations in Operation
The Netherlands continues to deliver impressive results. In June alone, the number of active units with our partner grew by 21%, with an additional 21% growth expected in July based on the current pipeline.

Our partner drove more than 300 kilometers in a single week to meet with partners, deliver Dosell units, and identify specific needs in each organization. The Netherlands now has over 30 care organizations using Dosell – clear proof of both the demand and scalability of the solution.

Unlike Sweden, several Dutch organizations choose to launch during the summer. As one partner put it: “We have to start now – we simply don’t have the resources to help our users manage their medication without Dosell.”

At the same time, development of further integrations with other platforms is ongoing, making it easier for new organizations to implement Dosell. Several existing customers are also significantly scaling up their usage volumes.

Other Markets: Rising Interest Across New Regions
We continue to engage in dialogue with several new markets expressing interest in implementing Dosell. The need for safer and more efficient medication management is global – and we see strong potential in scaling our model to more countries.

Thank you for following our journey – and a special thanks to all shareholders engaging with Dosell. Together, we continue shaping the future of medication management.

Growth is driven both by more municipalities and partners starting to use Dosell – and by existing customers prescribing more units per client. We are seeing broad and growing traction, even though we’re still coming from relatively modest volumes. That makes the strength of our growth rate all the more encouraging.

We are now entering the summer months, which traditionally means a somewhat slower pace due to holidays. But we look forward to ramping up again in the fall – firmly anchored in our long-term strategy.

Sweden: Growth in VGR and Increasing Demand Ahead of Autumn
In May, two more municipalities in the Västra Götaland region (VGR) began using Dosell, bringing our presence in the region to 14 municipalities. Several of these have started increasing their internal volumes and are receiving very positive feedback from both staff and users.

Two new municipalities have approved pilot projects with Dosell set to start right after summer. We’ve also held numerous presentations for municipalities now considering launching their own pilots – a clear sign of the strong momentum we’re experiencing in the Swedish public care sector.

At Vitalis, the Nordic region’s leading event for health and social care, we gained strategic traction – both through our presence and by presenting collaborations with Tamro, JDM Innovation, and Phoenix Group. The reaction from visitors was overwhelmingly positive, summarized best by the comment: “Finally, two solutions in one system!”

Especially appreciated was our joint stage appearance with ATEA and Ulricehamn Municipality, where Ulricehamn shared their successful implementation and how their “slow and steady” approach has led to stable, positive development. Many home care teams in the municipality are now reaching out, eager to start using Dosell themselves.

We also participated in Senior Day in Kungsträdgården, where we received great interest in our consumer solution. At the same time, our partner Zafe exhibited at the Dementia Days event, where Dosell attracted significant attention for its value in early intervention for cognitive impairment. The new Social Services Act emphasizes this very need – and many now see Dosell as a key part of the solution.

Spain: Pharmacy Network and Interest from Private Care Providers
In Spain, our partner Ti Medi continues rolling out Dosell through the national pharmacy network, which includes over 1,500 pharmacies.

Following strong media attention in April, private care providers have also started to show interest in Dosell. Our B2B solution is now being actively presented to these providers, who see the opportunity to complement their existing care structures with a digital solution that enhances independence and safety in medication management.

The Netherlands: Continued Growth and Trade Fair Momentum
In the Netherlands, growth continues at a rapid pace. Our customer TCCN is highly engaged and has established an efficient approach for broad outreach – already leading to concrete meetings with new stakeholders. At the same time, their existing customers are increasing their volumes month over month.

Dosell TV has generated strong interest, and our presence at the April trade fair served as a clear catalyst for new contacts. Several of these are now in the quotation or implementation phase. The combination of proactive sales, a strong network, and a value-driven offering that meets real needs gives us excellent conditions for continued expansion together with TCCN.

Strategic Partnership – LOI with JDM Innovation
In May, we signed a Letter of Intent with JDM Innovation, aiming to establish a strategic partnership in Europe. JDM is a well-established player in logistics, automation, and medical technology, working with both international pharmaceutical companies and pharmacy chains.

The partnership creates opportunities to integrate our technologies and opens doors to new markets in Europe. Discussions around joint pilots are already underway, and we see great potential in driving efficiency and safe medication management together in new markets.

Celebrate the 1,000-Unit Milestone with Us – Investor Evening June 12
To mark our achievement of surpassing 1,000 active units, we’re inviting you to an investor evening in Stockholm – on Thursday, June 12.

We sincerely hope as many shareholders as possible will take this opportunity to come, meet our team in person, ask questions, and get deeper insight into our journey and future vision. It’s a great chance to connect – and to experience Dosell live.

Welcome – we look forward to seeing you! Register here: https://forms.office.com/e/8qHzwLu5S8

Thank You for Your Trust – Together We Are Shaping the Future of Medication Management
iZafe Group is in a phase of strong commercial momentum. May’s results confirm both the direction and pace of our progress. We’re strengthening our partnerships, expanding our network, and building on a model that has now proven both scalable and effective.

Thank you for following our journey – and we warmly welcome you to the investor evening on Thursday, June 12.

To celebrate this achievement, the company invites shareholders, partners, healthcare professionals and other stakeholders to an exclusive event at its Stockholm office on June 12.

“This milestone is both personal and strategic. Reaching 1,000 Dosell units in operation proves that we’ve made it through the most challenging phase – building a stable, scalable and in-demand solution. Now we’re ready to grow in earnest. None of this would have been possible without the tremendous dedication of our team, our partners, and our shareholders who believed in us every step of the way. I look forward to sharing the next chapter with you,” says Anders Segerström, CEO of iZafe Group.

During the evening, we will share the journey toward reaching 1,000 active Dosell units – the challenges we’ve faced, the key turning points, and why this moment represents a breakthrough for both our company and the digital healthcare sector.

You’ll also get a glimpse of what’s coming next – our strategic goals, technical roadmap, and how we plan to scale up the business both in Sweden and internationally.

Food and drinks will be served in a relaxed setting where you’ll have the opportunity to connect with the Dosell team, fellow shareholders, healthcare innovators, and industry professionals.

Event Details:

• Date: Wednesday, June 12
• Time: From 6:00 PM
• Location: iZafe Group HQ, David Bagares Gata 3A, Stockholm
• Registration: https://forms.office.com/e/8qHzwLu5S8

Please note that registration is required and space is limited – spots will be allocated on a first-come, first-served basis.

About Dosell
Dosell is a medical technology solution that ensures the right person takes the right medication at the right time. The product is specifically designed to prevent double dosing and improve adherence – one of the greatest challenges in modern healthcare. Dosell is currently used by municipalities, private care providers and partners across Europe.

JDM has more than 40 years of experience in digital healthcare solutions and is the developer of Smila – an automatic medication dispenser already in use in Finland and Denmark. In Sweden, Smila is being introduced in collaboration with Tamro AB. The PHOENIX group, to which both JDM and Tamro belong, is the European leader in pharmaceutical wholesale, pharmacy retail, and services for the pharmaceutical industry with operations in 29 healthcare markets, providing a strong foundation for European expansion.

Dosell, developed by iZafe, is a Swedish medication robot used in elder care to ensure safe and accurate medication intake at home. The solution is currently established in a growing number of municipalities in Sweden and care organizations in the Netherlands and Spain, with increasing interest from other European markets. The technology has proven to reduce medication errors, enhance patient safety, and save valuable time for healthcare staff – making it possible to deliver high-quality care to more individuals.

Through this partnership, two complementary solutions are brought together in one integrated platform. Municipalities and care providers gain access to a unified system where a single training and technical integration unlock two proven technologies – streamlining procurement, implementation, and day-to-day use.

“This is an important strategic step for iZafe. By combining our solution with Smila and leveraging PHOENIX group’s strong presence in Europe, we are creating new opportunities for growth. Together, we are making it easier for municipalities and care providers to deliver safe and effective medication management to more users,” says Anders Segerström, CEO of iZafe Group.

Both iZafe and JDM advocate that different users have different needs. With this new platform, municipalities can easily offer tailored solutions based on each user’s abilities – without compromising on safety or ease of use. The platform ensures smooth implementation and effective daily operations, helping staff save time and enabling more people to receive high-quality care.

“Dosell is a perfect complement to Smila. Together, we can offer a strong end-to-end solution on one platform that simplifies the implementation of digital medication management for municipalities across Europe,” says Martin Lafleur, CEO of JDM Innovation GmbH.

This week, Dosell will exhibit together with Tamro at Vitalis – the Nordic region’s leading event for the future of health, care, and welfare technology. The collaboration will be presented under the joint message: “Two brands. One vision. One platform.”

Dosell continues to earn trust – both as a practical everyday tool and as a key enabler in the transition to future-oriented healthcare. Our momentum remains strong, and the interest from new municipalities and partners shows that the market is moving.

Sweden: Broad Implementation in VGR and Strong Demand
In April, two additional municipalities in the Västra Götaland Region (VGR) launched Dosell. In total, 12 municipalities in the region are now operational, and we’re seeing most of them move from pilot projects into broad implementation. This, in turn, has encouraged other municipalities – previously hesitant – to reach out and express interest in introducing Dosell.

We also conducted 10 demonstrations for municipalities currently evaluating pilot projects. One municipality launched a pilot in April, and the results so far have been very positive – no alerts have been triggered, and users report high satisfaction.

In addition, we are now engaged in exciting conversations with new potential partners who are highly interested in Dosell and its user-friendly design. We are in a phase where more stakeholders are recognizing both the need for and the potential of a solution that simplifies care, reduces strain, and empowers users.

We also participated in Seniors’ Day on May 6 in Stockholm’s Kungsträdgården – a gathering for over 60,000 seniors. We presented both Dosell and our consumer version and were met with strong interest from the target audience.
The overall development in Sweden demonstrates that our solution has gained a firm foothold and continues to grow organically through strong results and word-of-mouth.

The Netherlands: 21% Growth and New Clients from the Expo
In the Netherlands, our partner TCCN continues to deliver strong results. The number of active Dosell units increased by 21% from March to April, and the customer base is expanding.

Following the April expo, around 25 new leads were generated, leading to four meetings and one official offer. The first broadcast of Dosell TV also sparked significant interest, providing more organizations with insight into how Dosell works in practice.

The combination of satisfied end-users, innovative outreach, and a growing partner network provides a solid foundation for continued growth through the spring.

Spain: Market Launch and National TV Exposure
In Spain, Dosell has now entered the market through our partner Ti Medi and the Savioo Home concept. After participating in expos in Barcelona and France, we are now seeing increasing media coverage.

On April 26, Dosell appeared on Spanish national television in the program Aruser on La Sexta – one of the country’s largest TV channels. Host Alfonso Arús and his panel expressed strong support for the Savioo concept and emphasized the solution’s value for elderly individuals and those with complex medication routines. This provides clear proof that Dosell is gaining attention and credibility among the general public.

Over 50 pharmacies have shown interest in offering Savioo Home, which is now being launched nationally. We hope to see a tangible increase in sales in the coming months.

Dosell’s visibility in Spain strengthens our brand in a strategically important market and sets the stage for future volume growth.

To Our Shareholders – A Solid Foundation for Growth
iZafe Group remains in a development phase – but April clearly demonstrates that our strategy is bearing fruit. We are strengthening our position in Sweden through expanded cooperation in VGR, deepening our presence in Europe through new client relationships in the Netherlands, and reaching the general public in Spain through national TV.

At the same time, we are continuously engaging in new partnership discussions, and we see more readiness than ever to take action. The demand for safe, efficient medication management is growing rapidly – and Dosell is well positioned to meet that challenge.

Thank you for your continued trust and for following our journey forward.